CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 40 enrolled
Drug / intervention
Moxifloxacin +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00414011
NCT00414011N/ACompleted
CompareCT.gov

Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)

Walter Reed Army Medical Center·interventional·Posted Dec 20, 2006·Updated Jul 17, 2013

In Brief

A clinical study evaluating Moxifloxacin and Gatifloxacin for Epithelium, Corneal. Completed, enrolled 40 participants across 1 site.

Detailed Summary

The purpose of this study is a prospective,double-blinded, randomized trial to compare the rate of healing following PRK after the use of two commercially available 4th generation fluoroquinolones, moxifloxacin and gatifloxacin.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsEpithelium, Corneal
CountriesUnited States
Collaborators--

Timeline

N/ACompletedFinished
20052006200720082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedDec 20, 2006
Primary CompletionFeb 1, 2005
TodayJul 2, 2026
Posted 19.5 years ago

Interventions

Moxifloxacindrug

1 drop 4 times daily for 1 week or until complete re-epithelization (usually 3-4 days) after surgery

Gatifloxacindrug

1 drop 4 times daily for 1 week or until complete re-epithelization (usually 3-4 days) after surgery